Correlation Between Amicus Therapeutics and Tilray

Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Tilray at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Tilray into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Amicus Therapeutics and Tilray Inc, you can compare the effects of market volatilities on Amicus Therapeutics and Tilray and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Tilray. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Tilray.

Diversification Opportunities for Amicus Therapeutics and Tilray

0.31

Correlation Coefficient

Amicus Therapeutics  Tilray

Weak diversification

The 3 months correlation between Amicus and Tilray is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Tilray Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tilray Inc and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Tilray. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tilray Inc has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Tilray go up and down completely randomly.

Pair Corralation between Amicus Therapeutics and Tilray

Given the investment horizon of 90 days Amicus Therapeutics is expected to generate 0.39 times more return on investment than Tilray. However, Amicus Therapeutics is 2.54 times less risky than Tilray. It trades about 0.04 of its potential returns per unit of risk. Tilray Inc is currently generating about -0.38 per unit of risk. If you would invest  931.00  in Amicus Therapeutics on December 2, 2024 and sell it today you would earn a total of  18.00  from holding Amicus Therapeutics or generate 1.93% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Amicus Therapeutics  vs.  Tilray Inc

Amicus Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Amicus Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Tilray Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tilray Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Amicus Therapeutics and Tilray

The main advantage of trading using opposite Amicus Therapeutics and Tilray positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Tilray can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tilray will offset losses from the drop in Tilray's long position.

The idea behind Amicus Therapeutics and Tilray Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.